Bids for Indian pharma giant turn hostile

The acquisition of India’s biggest drug maker, Ranbaxy, by Japanese pharmaceutical company, Daiichi Sankyo, has been thrown into some doubt amid rumours of a hostile takeover bid for the generic company from Pfizer.
The agreement, made last week…

Get unlimited access to all IAM content